We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -5.71% | 1.65 | 1.60 | 1.70 | 1.90 | 1.625 | 1.75 | 15,893,319 | 11:54:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.32 | 12.79M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/5/2021 17:13 | How is the price doing in US market if still open? | 78steve | |
17/5/2021 16:35 | Closed at a 3 month high on decent volume.Bodes well for more gains tomorrow. | parob | |
17/5/2021 16:35 | Hoping my double up today sneaked in under 55p. I left it with my broker and haven't heard what price he got yet. | donaferentes | |
17/5/2021 16:30 | and a little jump at the end to get the share price rise to around 10%. Which...as the man says in the Fast Show "Is nice" | purchaseatthetop | |
17/5/2021 16:01 | shandypants....IMO this is what the American NEDs are there for. I bet they are running the US launch and that is why it will happen. They would never have come onboard without a serious amount of technical and logistical control and certainty. That is why the RNS of the two NEDs was so critical in me adding and adding. It meant that STX were (finally) being professional. That interview was in many ways dreadful. He got the incomes vague for years 1 to 3 and then did the same for years 4 to 5. No real clarity on the net income that would mean. Quite dreadful if you compare him to AN at AGL or JS at ITX who are clarity and conciseness. However, he did commit to Q2 2021. Period. | purchaseatthetop | |
17/5/2021 15:56 | Had another nibble today. So this should really be at 100p as it seems US launch going ahead shortly potential multimillion prospect. Dyor | 78steve | |
17/5/2021 15:53 | purchase - totally agree. End of Q2 launch always had a bit of contingency build in so he seems quite confident. He starts the interview by re-iterating this date so if there were any doubts he would have been more vague on dates. I think the later comment re a couple of months was just him being a little nervous (he's not a great presenter/interviewe | shandypants2 | |
17/5/2021 15:44 | My view is that the US Launch is 100% on track and will be delivered. There is no way any sane CEO would state that it was happening and release the interview just a few weeks before the deadline. I hope. | purchaseatthetop | |
17/5/2021 15:41 | My feeling is an "on track" US launch update plus a close above 60p and this will move very quickly to close the gap just above 100p on the chart. | parob | |
17/5/2021 15:36 | I just added at 55.95p as my last previous buy on 11/5/21 at 55.6p had just been exceeded. Not a problem getting 4,000. | purchaseatthetop | |
17/5/2021 15:32 | It is relentless and the weight of buying today could see this over 60p into the close imho... gla | andyview | |
17/5/2021 15:28 | Relentless buying and yes £1+ is a fair target - short term! | frrinvest | |
17/5/2021 15:19 | For anyone who hasn't watched the Funky Finance video here's the link:hTTps://www.you | parob | |
17/5/2021 15:17 | Funky finance can up trumps yet again . | brownbear3 | |
17/5/2021 14:27 | Shield first US OTC trade in a few mins | growthinvestor2001 | |
17/5/2021 14:16 | Yes I picked up on that comment a couple of months which if taken literally could mean mid July which would be yet another delay . we are already approaching 2 years since FDA approval just stating that Time is unbelievable it needs to be June from a confidence in management actually delivering on what’s been stated | best1467 | |
17/5/2021 13:45 | Thanks for link - I do hope TW isn't passing this off as his " mid May" update on US sales as it wasn't. Traders nearest he came to that was an apparently off the cuff remark of launching in "a couple of months". I expect sales before end Q2 as he has previously said ( I don't really as I have no confidence in the man in truth) I hope the new investors aren't disappointed so quickly. | powerp2 | |
17/5/2021 13:25 | Steve, 200p valued STX at c£234m (117 m shares in issue). Now with 216m shares it's equivalent to 108p. So hopefully, once we start selling in the US and sentiment improves £1 is the short term target. Tim on Proactive this morning | shandypants2 | |
17/5/2021 13:10 | thanks for that Parob...will listen later. hope it is 10% as good as AN on AGL at Zaks Traders. | purchaseatthetop | |
17/5/2021 12:25 | New interview out this morning.All sounds on track for the US launch.TW:"We are going to be launching Accrufer in the US by the end of the 2nd quarter"hTTps://tiny | parob | |
17/5/2021 11:48 | It will be very interesting to see at 14.30 today when the new OTCQX market opens for STX shares in the USA for the first time whether we get a major boost. Might happen. | purchaseatthetop | |
17/5/2021 11:23 | Lots of big buys going through today. | parob | |
17/5/2021 11:20 | innittowinit.......y | purchaseatthetop |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions